Data / Drug companies / Cabinet Health P.B.C.
Cabinet Health P.B.C.: 43 products in the FDA NDC directory, labeler code 82725
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Cabinet Health P.B.C. (labeler code 82725) lists 43 products in the FDA National Drug Code Directory, covering 17 finished drugs by generic name. By type: 42 over the counter drugs, 1 drugs for further processing. Its main marketing category is over the counter monograph drugs. The newest product started marketing on October 5, 2026.
The request: Watch Cabinet Health P.B.C. (FDA labeler code 82725): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 82725
- Products in commercial distribution
- 43
- Packages
- 64
- Finished drugs by generic name
- 17
- Prescription products
- 0
- Over the counter products
- 42
- Flagged as original packager
- 33 of 33 products that carry the flag
- Started marketing in the last 12 months
- 20
- Products with a marketing end date set
- 1
- Earliest marketing start
- October 1, 2024
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 21 | 48.8% |
| Generic drugs (ANDA) | 20 | 46.5% |
| Drugs for further processing | 2 | 4.7% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 42 | 97.7% |
| Drugs for further processing | 1 | 2.3% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Diphenhydramine hydrochloride | 6 | 127 |
| Cetirizine hydrochloride | 5 | 119 |
| Fexofenadine hydrochloride | 5 | 65 |
| Phenylephrine hydrochloride | 3 | 77 |
| Loratadine | 3 | 125 |
| Dextromethorphan hydrobromide | 3 | 17 |
| Acetaminophen | 2 | 214 |
| Acetaminophen, diphenhydramine hydrochloride | 2 | 14 |
| Cetirizine 10mg | 2 | 1 |
| Levocetirizine dihydrochloride 5mg | 1 | 1 |
| Phenylephrine | 1 | 1 |
| Guaifenesin 400 mg | 1 | 8 |
| Esomeprazole magnesium 20mg | 1 | 1 |
| Ibuprofen 200mg | 1 | 7 |
| Acetaminophen, aspirin, caffeine | 1 | 48 |
| Omeprazole 20mg | 1 | 2 |
| Famotidine 20mg | 1 | 3 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 36 | 83.7% |
| Capsule, liquid filled | 4 | 9.3% |
| Capsule, delayed release | 1 | 2.3% |
| Capsule, gelatin coated | 1 | 2.3% |
| Tablet, delayed release | 1 | 2.3% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| GoodMeds Nighttime Cold and Flu | 82725-4106 | Capsule, liquid filled | Over the counter monograph drugs | October 5, 2026 |
| GoodMeds Daytime Cold and Flu | 82725-4105 | Capsule, liquid filled | Over the counter monograph drugs | October 5, 2026 |
| GoodMeds Cetirizine 10mg | 82725-4203 | Tablet | Generic drugs (ANDA) | October 1, 2026 |
| ValuMeds Cetirizine 10mg | 82725-1203 | Tablet | Generic drugs (ANDA) | October 1, 2026 |
| GoodMeds Ibuprofen 200mg | 82725-4029 | Tablet | Generic drugs (ANDA) | September 14, 2026 |
| GoodMeds Acid Reducer 24HR Esomeprazole Magnesium Delayed-Release 20mg | 82725-4053 | Capsule, delayed release | Generic drugs (ANDA) | August 17, 2026 |
| GoodMeds 24HR Acid Reducer Omeprazole 20mg | 82725-4052 | Tablet, delayed release | Generic drugs (ANDA) | August 17, 2026 |
| Goodmeds extra strength pain relief acetaminophen | 82725-4027 | Tablet | Over the counter monograph drugs | July 9, 2026 |
| Goodmeds Famotidine 20mg 500 count | 82725-4047 | Tablet | Generic drugs (ANDA) | July 3, 2026 |
| GoodMeds Nasal Decongestant | 82725-4011 | Tablet | Over the counter monograph drugs | July 1, 2026 |
| Goodmeds Levocetirizine Dihydrochloride 5mg 365 count | 82725-4051 | Tablet | Generic drugs (ANDA) | June 30, 2026 |
| ValuMeds Nasal Decongestant PE Phenylephrine | 82725-1011 | Tablet | Over the counter monograph drugs | June 1, 2026 |
| Goodmeds Non-Drowsy Nasal Decongestant PE | 82725-4111 | Tablet | Over the counter monograph drugs | May 15, 2026 |
| Goodmeds Allergy Relief | 82725-4201 | Tablet | Over the counter monograph drugs | May 10, 2026 |
| Goodmeds Allergy Relief Diphenhydramine HCl | 82725-4001 | Tablet | Over the counter monograph drugs | April 15, 2026 |
| Goodmeds all day allergy relief cetirizine hcl | 82725-4103 | Tablet | Generic drugs (ANDA) | April 10, 2026 |
| Goodmeds Non Drowsy Allergy Relief | 82725-4202 | Tablet | Generic drugs (ANDA) | February 10, 2026 |
| Goodmeds cough relief dextromethorphan hbr | 82725-4110 | Capsule, gelatin coated | Over the counter monograph drugs | February 1, 2026 |
| Goodmeds Allergy Relief Diphenhydramine HCl | 82725-4101 | Tablet | Over the counter monograph drugs | February 1, 2026 |
| Goodmeds Extra Strength Pain Relief PM | 82725-4124 | Tablet | Over the counter monograph drugs | November 11, 2025 |
| Valumeds non-drowsy allergy relief fexofenadine hcl | 82725-1202 | Tablet | Generic drugs (ANDA) | November 1, 2025 |
| Fexofenadine hydrochloride | 82725-0102 | Tablet | Drugs for further processing | October 25, 2025 |
| Goodmeds Non-Drowsy Cough Relief | 82725-4010 | Capsule, liquid filled | Over the counter monograph drugs | October 10, 2025 |
| ValuMeds Allergy Relief Loratadine | 82725-1142 | Tablet | Generic drugs (ANDA) | October 1, 2025 |
| Loratadine | 82725-0142 | Tablet | Generic drugs (ANDA) | October 1, 2025 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.